| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.61e-07 | 66 | 74 | 6 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.61e-07 | 66 | 74 | 6 | GO:0001098 | |
| GeneOntologyMolecularFunction | TFIIF-class transcription factor complex binding | 1.35e-05 | 2 | 74 | 2 | GO:0001096 | |
| GeneOntologyMolecularFunction | histone binding | 5.65e-05 | 265 | 74 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | chromatin binding | 8.26e-05 | 739 | 74 | 11 | GO:0003682 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 9.33e-05 | 64 | 74 | 4 | GO:0140296 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.16e-04 | 206 | 74 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 1.34e-04 | 27 | 74 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.85e-04 | 30 | 74 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.04e-04 | 31 | 74 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | methylated histone binding | 2.93e-04 | 86 | 74 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 3.20e-04 | 88 | 74 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 3.74e-04 | 8 | 74 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 4.06e-04 | 39 | 74 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 5.80e-04 | 44 | 74 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 5.98e-04 | 10 | 74 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 6.20e-04 | 45 | 74 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 7.29e-04 | 11 | 74 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.81e-03 | 65 | 74 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.06e-03 | 68 | 74 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.15e-03 | 69 | 74 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.33e-03 | 71 | 74 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.47e-03 | 20 | 74 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | rRNA binding | 3.16e-03 | 79 | 74 | 3 | GO:0019843 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat modifying activity | 3.26e-03 | 23 | 74 | 2 | GO:0140994 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 1.42e-08 | 127 | 72 | 8 | GO:0006368 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 3.81e-08 | 144 | 72 | 8 | GO:0006354 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RTF1 SETD1A MBTD1 SETD2 GTF2E1 THRA SETD1B BRD2 UBR5 BRD4 ZMYND8 CHD1 CHD2 FBXL19 CBX2 INO80E | 2.60e-07 | 999 | 72 | 16 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | RTF1 SETD1A MBTD1 SETD2 SETD1B BRD2 UBR5 BRD4 ZMYND8 CHD1 CHD2 FBXL19 CBX2 INO80E | 2.20e-06 | 896 | 72 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | box H/ACA snoRNP assembly | 1.20e-05 | 2 | 72 | 2 | GO:0000493 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell activation | 1.49e-05 | 89 | 72 | 5 | GO:0046635 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 4.88e-05 | 275 | 72 | 7 | GO:0016072 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell differentiation | 7.40e-05 | 64 | 72 | 4 | GO:0046638 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell activation | 1.35e-04 | 141 | 72 | 5 | GO:0046634 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.38e-04 | 226 | 72 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.49e-04 | 144 | 72 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | rRNA processing | 1.52e-04 | 230 | 72 | 6 | GO:0006364 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.41e-04 | 741 | 72 | 10 | GO:0006338 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 2.57e-04 | 162 | 72 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | hemopoiesis | SETD1A THRA PTPRC BRD2 KLF6 DROSHA BRD4 GON4L SNRK CHD2 NKAP PAF1 AP3B1 | 2.82e-04 | 1223 | 72 | 13 | GO:0030097 |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 3.15e-04 | 38 | 72 | 3 | GO:0035987 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell differentiation | 3.15e-04 | 93 | 72 | 4 | GO:0046637 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 3.15e-04 | 93 | 72 | 4 | GO:0034243 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell lineage commitment | 3.32e-04 | 8 | 72 | 2 | GO:2000330 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 3.33e-04 | 266 | 72 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | stem cell development | 4.32e-04 | 101 | 72 | 4 | GO:0048864 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 5.00e-04 | 105 | 72 | 4 | GO:0032784 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 5.56e-04 | 537 | 72 | 8 | GO:0030098 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 5.76e-04 | 540 | 72 | 8 | GO:1903706 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 6.48e-04 | 11 | 72 | 2 | GO:2000328 | |
| GeneOntologyBiologicalProcess | endoderm formation | 6.70e-04 | 49 | 72 | 3 | GO:0001706 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 6.98e-04 | 306 | 72 | 6 | GO:0048863 | |
| GeneOntologyBiologicalProcess | small nucleolar ribonucleoprotein complex assembly | 7.75e-04 | 12 | 72 | 2 | GO:0000491 | |
| GeneOntologyBiologicalProcess | positive T cell selection | 8.43e-04 | 53 | 72 | 3 | GO:0043368 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 8.90e-04 | 54 | 72 | 3 | GO:0032968 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.05e-09 | 56 | 74 | 7 | GO:0008023 | |
| GeneOntologyCellularComponent | super elongation complex | 2.16e-09 | 6 | 74 | 4 | GO:0032783 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RTF1 NOLC1 SETD1A GTF2E1 GTF2F1 THRA SETD1B AFF2 EAF2 DROSHA BRD4 GPATCH1 GON4L AFF1 PAF1 CWC22 AFF4 CBX2 INO80E | 2.08e-07 | 1377 | 74 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | transferase complex | RTF1 SETD1A MBTD1 GTF2E1 GTF2F1 SETD1B DCAF8 DCAF8L1 BRD4 DCAF8L2 FBXL19 PAF1 DCAF5 CBX2 | 6.08e-06 | 963 | 74 | 14 | GO:1990234 |
| GeneOntologyCellularComponent | Cul4-RING E3 ubiquitin ligase complex | 9.75e-06 | 38 | 74 | 4 | GO:0080008 | |
| GeneOntologyCellularComponent | chromatin | SETD1A MBTD1 THRA BRD2 KLF6 UBR5 BRD4 ZMYND8 DVL3 ANKRD11 NPAS3 GON4L CHD1 CHD2 AFF4 CBX2 INO80E | 1.23e-05 | 1480 | 74 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear body | GCNA NOLC1 SETD1A PPIG SETD1B BRD2 AFF2 EAF2 GON4L RP9 CWC22 RFWD3 SHQ1 | 1.52e-05 | 903 | 74 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | fibrillar center | 1.91e-05 | 156 | 74 | 6 | GO:0001650 | |
| GeneOntologyCellularComponent | nuclear speck | 1.40e-04 | 431 | 74 | 8 | GO:0016607 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | RTF1 MBTD1 GTF2E1 GTF2F1 DCAF8 DCAF8L1 DROSHA DCAF8L2 FBXL19 PAF1 DCAF5 CBX2 | 1.46e-04 | 972 | 74 | 12 | GO:0140535 |
| GeneOntologyCellularComponent | Cdc73/Paf1 complex | 2.57e-04 | 7 | 74 | 2 | GO:0016593 | |
| GeneOntologyCellularComponent | RNA polymerase II, holoenzyme | 2.81e-04 | 89 | 74 | 4 | GO:0016591 | |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 6.96e-04 | 113 | 74 | 4 | GO:0055029 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 7.68e-04 | 116 | 74 | 4 | GO:0000428 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 8.45e-04 | 119 | 74 | 4 | GO:0030880 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 9.34e-04 | 212 | 74 | 5 | GO:0031461 | |
| GeneOntologyCellularComponent | site of DNA damage | 1.42e-03 | 137 | 74 | 4 | GO:0090734 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 1.44e-03 | 16 | 74 | 2 | GO:0048188 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 1.55e-03 | 352 | 74 | 6 | GO:0000151 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 1.62e-03 | 17 | 74 | 2 | GO:0090443 | |
| GeneOntologyCellularComponent | Ino80 complex | 1.62e-03 | 17 | 74 | 2 | GO:0031011 | |
| GeneOntologyCellularComponent | euchromatin | 2.13e-03 | 72 | 74 | 3 | GO:0000791 | |
| GeneOntologyCellularComponent | INO80-type complex | 4.40e-03 | 28 | 74 | 2 | GO:0097346 | |
| MousePheno | abnormal craniofacial morphology | AKAP6 MBTD1 SETD2 THRA BRD2 TCOF1 UBR5 DSPP BRD4 DVL3 ANKRD11 GON4L CHD1 FBXL19 AP3B1 DCAF5 AFF4 CBX2 | 1.76e-05 | 1372 | 62 | 18 | MP:0000428 |
| MousePheno | craniofacial phenotype | AKAP6 MBTD1 SETD2 THRA BRD2 TCOF1 UBR5 DSPP BRD4 DVL3 ANKRD11 GON4L CHD1 FBXL19 AP3B1 DCAF5 AFF4 CBX2 | 1.76e-05 | 1372 | 62 | 18 | MP:0005382 |
| MousePheno | decreased small intestine length | 5.79e-05 | 3 | 62 | 2 | MP:0013958 | |
| Domain | TF_AF4/FMR2 | 2.10e-07 | 4 | 71 | 3 | IPR007797 | |
| Domain | AF-4 | 2.10e-07 | 4 | 71 | 3 | PF05110 | |
| Domain | N-SET | 1.42e-05 | 2 | 71 | 2 | PF11764 | |
| Domain | COMPASS_Set1_N-SET | 1.42e-05 | 2 | 71 | 2 | IPR024657 | |
| Domain | Vasculin_fam | 1.42e-05 | 2 | 71 | 2 | IPR028128 | |
| Domain | Vasculin | 1.42e-05 | 2 | 71 | 2 | PF15337 | |
| Domain | N-SET | 1.42e-05 | 2 | 71 | 2 | SM01291 | |
| Domain | Fam133 | 1.42e-05 | 2 | 71 | 2 | IPR026766 | |
| Domain | Post-SET_dom | 2.85e-05 | 16 | 71 | 3 | IPR003616 | |
| Domain | PostSET | 2.85e-05 | 16 | 71 | 3 | SM00508 | |
| Domain | POST_SET | 2.85e-05 | 16 | 71 | 3 | PS50868 | |
| Domain | Chromodomain_CS | 4.12e-05 | 18 | 71 | 3 | IPR023779 | |
| Domain | DUF4208 | 4.26e-05 | 3 | 71 | 2 | PF13907 | |
| Domain | DUF4208 | 4.26e-05 | 3 | 71 | 2 | SM01176 | |
| Domain | DUF4208 | 4.26e-05 | 3 | 71 | 2 | IPR025260 | |
| Domain | BET | 8.51e-05 | 4 | 71 | 2 | PF17035 | |
| Domain | NET_dom | 8.51e-05 | 4 | 71 | 2 | IPR027353 | |
| Domain | NET | 8.51e-05 | 4 | 71 | 2 | PS51525 | |
| Domain | Chromo_domain | 1.01e-04 | 24 | 71 | 3 | IPR023780 | |
| Domain | Chromo | 1.29e-04 | 26 | 71 | 3 | PF00385 | |
| Domain | CHROMO_1 | 1.61e-04 | 28 | 71 | 3 | PS00598 | |
| Domain | CHROMO_2 | 1.61e-04 | 28 | 71 | 3 | PS50013 | |
| Domain | Chromodomain-like | 2.41e-04 | 32 | 71 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 2.65e-04 | 33 | 71 | 3 | IPR000953 | |
| Domain | CHROMO | 2.65e-04 | 33 | 71 | 3 | SM00298 | |
| Domain | Bromodomain | 4.04e-04 | 38 | 71 | 3 | PF00439 | |
| Domain | WD40 | 4.52e-04 | 259 | 71 | 6 | PF00400 | |
| Domain | SET | 5.06e-04 | 41 | 71 | 3 | PF00856 | |
| Domain | BROMODOMAIN_2 | 5.06e-04 | 41 | 71 | 3 | PS50014 | |
| Domain | WD40 | 5.42e-04 | 268 | 71 | 6 | SM00320 | |
| Domain | BROMO | 5.43e-04 | 42 | 71 | 3 | SM00297 | |
| Domain | Bromodomain | 5.43e-04 | 42 | 71 | 3 | IPR001487 | |
| Domain | - | 5.43e-04 | 42 | 71 | 3 | 1.20.920.10 | |
| Domain | WD40_repeat | 5.85e-04 | 272 | 71 | 6 | IPR001680 | |
| Domain | WD_REPEATS_2 | 6.69e-04 | 279 | 71 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 6.69e-04 | 279 | 71 | 6 | PS50294 | |
| Domain | SET | 7.11e-04 | 46 | 71 | 3 | SM00317 | |
| Domain | SET_dom | 9.08e-04 | 50 | 71 | 3 | IPR001214 | |
| Domain | SET | 9.08e-04 | 50 | 71 | 3 | PS50280 | |
| Domain | WD40_repeat_dom | 9.26e-04 | 297 | 71 | 6 | IPR017986 | |
| Domain | - | 1.66e-03 | 333 | 71 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.71e-03 | 335 | 71 | 6 | IPR015943 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.30e-08 | 81 | 50 | 7 | M865 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 5.14e-08 | 58 | 50 | 6 | M805 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 4.48e-07 | 83 | 50 | 6 | MM15314 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 1.98e-06 | 59 | 50 | 5 | MM14504 | |
| Pathway | REACTOME_MRNA_SPLICING | 9.86e-05 | 212 | 50 | 6 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.70e-04 | 283 | 50 | 6 | M13087 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 5.02e-04 | 44 | 50 | 3 | M13720 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 5.72e-04 | 46 | 50 | 3 | MM14933 | |
| Pathway | REACTOME_MRNA_SPLICING | 7.06e-04 | 201 | 50 | 5 | MM15411 | |
| Pubmed | 1.59e-12 | 156 | 75 | 10 | 22952844 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NOLC1 SETD2 GTF2F1 GPBP1L1 DCAF8 EAF2 TCOF1 UBR5 DROSHA NAF1 WDR70 DVL3 SNRK PAF1 AP3B1 ANKZF1 RFWD3 SHQ1 | 5.88e-12 | 1038 | 75 | 18 | 26673895 |
| Pubmed | NOLC1 MBTD1 SETD2 THRA DCAF8 BRD2 UTP25 TCOF1 UBR5 DROSHA BRD4 NAF1 ZMYND8 NKAP DCAF5 AFF4 PTCD3 INO80E | 1.93e-11 | 1116 | 75 | 18 | 31753913 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FAM133B NOLC1 SETD1A PPIG VRK3 ZCCHC10 TCOF1 NKAPD1 ZMYND8 DVL3 KRI1 CHD1 CHD2 RP9 NKAP PAF1 AP3B1 CWC22 PTCD3 | 3.30e-11 | 1318 | 75 | 19 | 30463901 |
| Pubmed | FAM133B SETD2 GTF2F1 GPBP1L1 BRD2 VRK3 UTP25 DROSHA ZMYND8 ANKRD11 GON4L CHD1 CHD2 NKAP AP3B1 ANKZF1 AFF4 PTCD3 INO80E | 2.84e-10 | 1497 | 75 | 19 | 31527615 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 7.20e-09 | 270 | 75 | 9 | 24366813 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 8.83e-09 | 69 | 75 | 6 | 28481362 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 SETD2 BRD2 BRD4 GPATCH1 ZMYND8 ANKRD11 KRI1 CHD1 RP9 PAF1 CWC22 AFF4 CBX2 | 1.47e-08 | 954 | 75 | 14 | 36373674 |
| Pubmed | 2.53e-08 | 40 | 75 | 5 | 28805822 | ||
| Pubmed | PPIG VRK3 TCOF1 FAM133A DROSHA NKAPD1 NAF1 KRI1 CHD2 NKAP AP3B1 ANKZF1 AFF4 CBX2 PTCD3 INO80E | 2.97e-08 | 1371 | 75 | 16 | 36244648 | |
| Pubmed | RTF1 NOLC1 SETD2 PPIG GTF2E1 GTF2F1 BRD2 UBR5 BRD4 WDR70 ZMYND8 CHD1 CHD2 PAF1 | 3.15e-08 | 1014 | 75 | 14 | 32416067 | |
| Pubmed | A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency. | 3.85e-08 | 4 | 75 | 3 | 26830226 | |
| Pubmed | Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. | 3.85e-08 | 4 | 75 | 3 | 11923441 | |
| Pubmed | Mediation of Af4 protein function in the cerebellum by Siah proteins. | 3.85e-08 | 4 | 75 | 3 | 15459319 | |
| Pubmed | 7.32e-08 | 251 | 75 | 8 | 31076518 | ||
| Pubmed | 7.84e-08 | 99 | 75 | 6 | 34161765 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 MBTD1 SETD2 PPIG BRD2 VRK3 TCOF1 BRD4 GPATCH1 ZMYND8 ANKRD11 CHD2 PAF1 RFWD3 INO80E | 9.37e-08 | 1294 | 75 | 15 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 SETD2 PPIG PTPRC BRD2 TCOF1 BRD4 NAF1 ZMYND8 CTDP1 AFF1 NKAP | 9.82e-08 | 774 | 75 | 12 | 15302935 |
| Pubmed | 9.94e-08 | 103 | 75 | 6 | 32744500 | ||
| Pubmed | NOLC1 PPIG TNRC18 FAM193A DCAF8 TCOF1 UBR5 CHD1 RP9 NKAP DCAF5 | 1.60e-07 | 655 | 75 | 11 | 35819319 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.83e-07 | 283 | 75 | 8 | 30585729 | |
| Pubmed | 2.85e-07 | 300 | 75 | 8 | 28561026 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | RTF1 SETD2 PPIG GTF2E1 TCOF1 DROSHA STK26 AFF1 CHD2 NKAP AFF4 | 2.88e-07 | 695 | 75 | 11 | 23602568 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 3.94e-07 | 432 | 75 | 9 | 23455922 | |
| Pubmed | 5.35e-07 | 8 | 75 | 3 | 9765293 | ||
| Pubmed | 5.39e-07 | 222 | 75 | 7 | 37071664 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | RTF1 NOLC1 BRD2 UTP25 NKAPD1 STK26 AFF1 CHD1 CHD2 NKAP STK24 AFF4 | 5.51e-07 | 910 | 75 | 12 | 36736316 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 SETD2 GTF2E1 FAM193A TCOF1 GPATCH1 NAF1 WDR70 ZMYND8 CHD1 PAF1 AFF4 | 7.25e-07 | 934 | 75 | 12 | 33916271 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 7.40e-07 | 608 | 75 | 10 | 36089195 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.50e-07 | 341 | 75 | 8 | 32971831 | |
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 24565118 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 8.48e-07 | 148 | 75 | 6 | 32538781 | |
| Pubmed | 1.20e-06 | 157 | 75 | 6 | 30186101 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FAM133B NOLC1 PPIG GTF2F1 TCOF1 DROSHA NAF1 CHD2 RP9 NKAP PTCD3 | 1.24e-06 | 807 | 75 | 11 | 22681889 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RTF1 NOLC1 BRD2 UTP25 TCOF1 KRI1 CHD1 PAF1 CWC22 AFF4 CBX2 PTCD3 | 1.32e-06 | 989 | 75 | 12 | 36424410 |
| Pubmed | 1.57e-06 | 11 | 75 | 3 | 24367103 | ||
| Pubmed | 1.57e-06 | 11 | 75 | 3 | 20471949 | ||
| Pubmed | 2.04e-06 | 390 | 75 | 8 | 17643375 | ||
| Pubmed | 2.09e-06 | 12 | 75 | 3 | 9159119 | ||
| Pubmed | The little elongation complex regulates small nuclear RNA transcription. | 2.09e-06 | 12 | 75 | 3 | 22195968 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.23e-06 | 533 | 75 | 9 | 30554943 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.37e-06 | 398 | 75 | 8 | 35016035 | |
| Pubmed | 2.71e-06 | 13 | 75 | 3 | 24036311 | ||
| Pubmed | Transcriptional and posttranscriptional regulation of HIV-1 gene expression. | 2.71e-06 | 13 | 75 | 3 | 22355797 | |
| Pubmed | NOLC1 FAM193A DCAF8 BRD2 TCOF1 UBR5 TEX2 ANKRD11 KRI1 CHD1 PAF1 AP3B1 DCAF5 PTCD3 | 3.12e-06 | 1487 | 75 | 14 | 33957083 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 SETD2 PPIG BRD2 TCOF1 DROSHA BRD4 ZMYND8 CHD2 CWC22 AFF4 PTCD3 | 3.32e-06 | 1082 | 75 | 12 | 38697112 |
| Pubmed | AKAP6 NOLC1 MBTD1 PTPRC TEX2 NKAPD1 AFF1 CHD2 AP3B1 STK24 DCAF5 AFF4 | 3.39e-06 | 1084 | 75 | 12 | 11544199 | |
| Pubmed | 3.45e-06 | 14 | 75 | 3 | 25921070 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.19e-06 | 430 | 75 | 8 | 35044719 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 12732728 | ||
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 4.59e-06 | 2 | 75 | 2 | 25297984 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 37528066 | ||
| Pubmed | Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation. | 4.59e-06 | 2 | 75 | 2 | 32151278 | |
| Pubmed | BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. | 4.59e-06 | 2 | 75 | 2 | 23255218 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 24146614 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 24843025 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 12591941 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 24550110 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 23115324 | ||
| Pubmed | Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders. | 4.59e-06 | 2 | 75 | 2 | 37166351 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 26324948 | ||
| Pubmed | Suppression of the antiviral response by an influenza histone mimic. | 4.59e-06 | 2 | 75 | 2 | 22419161 | |
| Pubmed | In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). | 4.59e-06 | 2 | 75 | 2 | 38003223 | |
| Pubmed | Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2. | 4.59e-06 | 2 | 75 | 2 | 35839775 | |
| Pubmed | Brd4-Brd2 isoform switching coordinates pluripotent exit and Smad2-dependent lineage specification. | 4.59e-06 | 2 | 75 | 2 | 28588073 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 26007649 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 16940503 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 37490000 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 11355014 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 20036832 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 39066826 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.95e-06 | 588 | 75 | 9 | 38580884 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.95e-06 | 440 | 75 | 8 | 34244565 | |
| Pubmed | 5.15e-06 | 591 | 75 | 9 | 15231748 | ||
| Pubmed | 7.68e-06 | 18 | 75 | 3 | 19410543 | ||
| Pubmed | 7.89e-06 | 469 | 75 | 8 | 27634302 | ||
| Pubmed | Lost in transcription: molecular mechanisms that control HIV latency. | 9.10e-06 | 19 | 75 | 3 | 23518577 | |
| Pubmed | 9.48e-06 | 61 | 75 | 4 | 20305087 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RTF1 NOLC1 GTF2E1 GTF2F1 TCOF1 UBR5 NAF1 KRI1 CHD1 PAF1 AP3B1 ANKZF1 PTCD3 | 9.56e-06 | 1415 | 75 | 13 | 28515276 |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.09e-05 | 134 | 75 | 5 | 25452129 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 21123813 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 19215094 | ||
| Pubmed | Structural basis for Spt5-mediated recruitment of the Paf1 complex to chromatin. | 1.37e-05 | 3 | 75 | 2 | 24101474 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 37884088 | ||
| Pubmed | Molecular insight into the SETD1A/B N-terminal region and its interaction with WDR82. | 1.37e-05 | 3 | 75 | 2 | 37030068 | |
| Pubmed | Structural mechanism of CCM3 heterodimerization with GCKIII kinases. | 1.37e-05 | 3 | 75 | 2 | 23541896 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 22046413 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 23889253 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 37313815 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 31792058 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 30300821 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 28262505 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 21330300 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 25049379 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 24049186 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 12578358 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 33567280 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 15604408 | ||
| Pubmed | GRIM-1, a novel growth suppressor, inhibits rRNA maturation by suppressing small nucleolar RNAs. | 1.37e-05 | 3 | 75 | 2 | 21931644 | |
| Pubmed | CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage. | 1.37e-05 | 3 | 75 | 2 | 33022763 | |
| Interaction | PLCD3 interactions | RTF1 NOLC1 SETD1A KANK1 GPBP1L1 BRD2 ZCCHC10 TCOF1 BRD4 NAF1 WDR70 AFF1 FBXL19 AP3B1 CWC22 DCAF5 AFF4 SHQ1 | 1.98e-24 | 121 | 75 | 18 | int:PLCD3 |
| Interaction | PIP4K2A interactions | RTF1 NOLC1 SETD2 PPIG GTF2F1 KANK1 GPBP1L1 SETD1B BRD2 EAF2 ZCCHC10 TCOF1 BRD4 NAF1 AFF1 NKAP AP3B1 CWC22 AFF4 RFWD3 | 7.84e-23 | 216 | 75 | 20 | int:PIP4K2A |
| Interaction | DDX23 interactions | RTF1 NOLC1 SETD2 PPIG GTF2E1 GTF2F1 BRD2 TCOF1 UBR5 NKAPD1 BRD4 STK26 NAF1 WDR70 ANKRD11 KRI1 CHD1 CHD2 RP9 NKAP PAF1 CWC22 STK24 AFF4 | 5.27e-21 | 480 | 75 | 24 | int:DDX23 |
| Interaction | SYT2 interactions | RTF1 NOLC1 SETD1A KANK1 GPBP1L1 EAF2 UTP25 NAF1 WDR70 CTDP1 PAF1 AP3B1 CWC22 DCAF5 AFF4 | 9.07e-18 | 150 | 75 | 15 | int:SYT2 |
| Interaction | CT45A5 interactions | NOLC1 SETD1A KANK1 GPBP1L1 BRD2 UTP25 BRD4 NAF1 CTDP1 AP3B1 CWC22 AFF4 | 1.00e-16 | 78 | 75 | 12 | int:CT45A5 |
| Interaction | CAMKV interactions | NOLC1 JCAD TNRC18 BRD2 ZCCHC10 TCOF1 BRD4 NAF1 AFF1 AP3B1 CWC22 AFF4 | 1.76e-14 | 118 | 75 | 12 | int:CAMKV |
| Interaction | DENND2D interactions | 6.97e-13 | 36 | 75 | 8 | int:DENND2D | |
| Interaction | CSNK2B interactions | NOLC1 SETD2 DCAF8 BRD2 VRK3 TCOF1 FAM133A NKAPD1 BRD4 ZMYND8 CTDP1 ANKRD11 SNRK RP9 NKAP PAF1 RFWD3 CBX2 INO80E | 9.45e-13 | 625 | 75 | 19 | int:CSNK2B |
| Interaction | NFKBIL1 interactions | NOLC1 SETD1A SETD2 PPIG TNRC18 BRD2 ZCCHC10 AP3B1 CWC22 AFF4 | 1.73e-12 | 93 | 75 | 10 | int:NFKBIL1 |
| Interaction | JMJD6 interactions | SETD2 PPIG GTF2F1 BRD2 ZCCHC10 FAM133A NKAPD1 BRD4 NAF1 RP9 NKAP AP3B1 | 1.32e-11 | 205 | 75 | 12 | int:JMJD6 |
| Interaction | EPB41L3 interactions | RTF1 SETD1A PPIG TNRC18 KANK1 ZCCHC10 NAF1 AFF1 NKAP AP3B1 CWC22 AFF4 RFWD3 | 2.22e-11 | 272 | 75 | 13 | int:EPB41L3 |
| Interaction | PLCD4 interactions | 2.32e-11 | 32 | 75 | 7 | int:PLCD4 | |
| Interaction | CSNK2A1 interactions | RTF1 NOLC1 SETD1A GTF2F1 PTPRC BRD2 ZCCHC10 TCOF1 FAM133A NKAPD1 BRD4 NAF1 ZMYND8 CTDP1 DVL3 ANKRD11 SNRK RP9 NKAP PAF1 CBX2 | 2.33e-11 | 956 | 75 | 21 | int:CSNK2A1 |
| Interaction | POLR1G interactions | RTF1 NOLC1 GTF2E1 GTF2F1 BRD2 TCOF1 BRD4 WDR70 ZMYND8 ANKRD11 KRI1 CHD1 CHD2 PAF1 AFF4 CBX2 | 2.59e-11 | 489 | 75 | 16 | int:POLR1G |
| Interaction | FGF12 interactions | 3.39e-11 | 87 | 75 | 9 | int:FGF12 | |
| Interaction | EPB41L5 interactions | SETD1A GPBP1L1 DCAF8 BRD2 GPBP1 ZCCHC10 NAF1 CTDP1 RP9 AP3B1 CWC22 DCAF5 AFF4 | 6.94e-11 | 298 | 75 | 13 | int:EPB41L5 |
| Interaction | NOP56 interactions | RTF1 NOLC1 GTF2F1 BRD2 KLF6 TCOF1 NKAPD1 BRD4 WDR70 ANKRD11 KRI1 CHD1 RP9 NKAP PAF1 AFF4 | 2.49e-10 | 570 | 75 | 16 | int:NOP56 |
| Interaction | BRD9 interactions | 5.00e-10 | 117 | 75 | 9 | int:BRD9 | |
| Interaction | C1orf226 interactions | 9.98e-10 | 53 | 75 | 7 | int:C1orf226 | |
| Interaction | ARRB2 interactions | RTF1 NOLC1 KANK1 GPBP1L1 BRD2 UTP25 TCOF1 UBR5 BRD4 TMEM74 WDR70 ANKRD11 AP3B1 AFF4 | 1.14e-09 | 454 | 75 | 14 | int:ARRB2 |
| Interaction | GRK5 interactions | 1.40e-09 | 182 | 75 | 10 | int:GRK5 | |
| Interaction | MDK interactions | 1.66e-09 | 91 | 75 | 8 | int:MDK | |
| Interaction | NIFK interactions | RTF1 NOLC1 GTF2F1 DCAF8 BRD2 KLF6 TCOF1 BRD4 ANKRD11 KRI1 RP9 AFF4 PTCD3 | 6.22e-09 | 431 | 75 | 13 | int:NIFK |
| Interaction | PIP4K2C interactions | 7.60e-09 | 159 | 75 | 9 | int:PIP4K2C | |
| Interaction | NOS1AP interactions | 9.39e-09 | 113 | 75 | 8 | int:NOS1AP | |
| Interaction | SNRNP40 interactions | SETD2 GTF2F1 GPBP1L1 TCOF1 UBR5 NKAPD1 BRD4 GPATCH1 KRI1 GON4L CHD1 RP9 PAF1 CWC22 CBX2 | 1.05e-08 | 637 | 75 | 15 | int:SNRNP40 |
| Interaction | FGF11 interactions | 1.36e-08 | 170 | 75 | 9 | int:FGF11 | |
| Interaction | SULF2 interactions | 1.41e-08 | 119 | 75 | 8 | int:SULF2 | |
| Interaction | TCEA1 interactions | 3.01e-08 | 131 | 75 | 8 | int:TCEA1 | |
| Interaction | EPB41L1 interactions | 3.12e-08 | 187 | 75 | 9 | int:EPB41L1 | |
| Interaction | BEND7 interactions | 5.87e-08 | 94 | 75 | 7 | int:BEND7 | |
| Interaction | MED17 interactions | 6.06e-08 | 202 | 75 | 9 | int:MED17 | |
| Interaction | NUP43 interactions | RTF1 SETD1A SETD2 SETD1B UBR5 GPATCH1 ZMYND8 ANKRD11 KRI1 GON4L CHD1 NKAP PAF1 CWC22 | 6.45e-08 | 625 | 75 | 14 | int:NUP43 |
| Interaction | ZNF330 interactions | RTF1 NOLC1 GTF2E1 GTF2F1 BRD2 ZMYND8 ANKRD11 KRI1 CHD1 PAF1 AFF4 CBX2 | 8.82e-08 | 446 | 75 | 12 | int:ZNF330 |
| Interaction | PAF1 interactions | 9.93e-08 | 214 | 75 | 9 | int:PAF1 | |
| Interaction | TERF2IP interactions | RTF1 SETD1A SETD2 GTF2F1 BRD4 WDR70 ZMYND8 ANKRD11 CHD1 PAF1 STK24 AFF4 CBX2 | 1.14e-07 | 552 | 75 | 13 | int:TERF2IP |
| Interaction | DHX8 interactions | 1.26e-07 | 292 | 75 | 10 | int:DHX8 | |
| Interaction | APEX1 interactions | RTF1 NOLC1 SETD2 CLSTN3 GTF2F1 FAM193A BRD2 ZCCHC10 TCOF1 DROSHA BRD4 WDR70 ZMYND8 CTDP1 ANKRD11 KRI1 PAF1 AFF4 CBX2 | 1.33e-07 | 1271 | 75 | 19 | int:APEX1 |
| Interaction | MED26 interactions | 1.44e-07 | 107 | 75 | 7 | int:MED26 | |
| Interaction | NKAPD1 interactions | 1.49e-07 | 161 | 75 | 8 | int:NKAPD1 | |
| Interaction | H3C1 interactions | SETD1A SETD2 GTF2E1 GTF2F1 TNRC18 SETD1B BRD2 GPBP1 BRD4 ZMYND8 KRI1 CHD1 PAF1 AFF4 CBX2 PTCD3 | 1.60e-07 | 901 | 75 | 16 | int:H3C1 |
| Interaction | EDA interactions | 2.09e-07 | 113 | 75 | 7 | int:EDA | |
| Interaction | MCRS1 interactions | 2.20e-07 | 235 | 75 | 9 | int:MCRS1 | |
| Interaction | AFF4 interactions | 2.36e-07 | 115 | 75 | 7 | int:AFF4 | |
| Interaction | MED14 interactions | 2.37e-07 | 171 | 75 | 8 | int:MED14 | |
| Interaction | PSME3 interactions | MBTD1 GTF2F1 VRK3 EAF2 UTP25 ZCCHC10 BRD4 DVL3 RP9 FBXL19 CBX2 | 2.45e-07 | 398 | 75 | 11 | int:PSME3 |
| Interaction | THAP1 interactions | 2.98e-07 | 119 | 75 | 7 | int:THAP1 | |
| Interaction | WDR48 interactions | 3.09e-07 | 177 | 75 | 8 | int:WDR48 | |
| Interaction | CSNK2A2 interactions | RTF1 NOLC1 PTPRC BRD2 TCOF1 FAM133A NKAPD1 BRD4 ZMYND8 CTDP1 RP9 NKAP PAF1 CBX2 | 3.50e-07 | 718 | 75 | 14 | int:CSNK2A2 |
| Interaction | SP110 interactions | 3.54e-07 | 122 | 75 | 7 | int:SP110 | |
| Interaction | DHX40 interactions | 3.59e-07 | 249 | 75 | 9 | int:DHX40 | |
| Interaction | RNF151 interactions | 3.74e-07 | 123 | 75 | 7 | int:RNF151 | |
| Interaction | SNIP1 interactions | RTF1 NOLC1 PPIG GTF2E1 BRD2 ZCCHC10 TCOF1 GPATCH1 DVL3 NKAP CWC22 | 3.89e-07 | 417 | 75 | 11 | int:SNIP1 |
| Interaction | PES1 interactions | 4.83e-07 | 258 | 75 | 9 | int:PES1 | |
| Interaction | INO80E interactions | 4.86e-07 | 79 | 75 | 6 | int:INO80E | |
| Interaction | EAF1 interactions | 4.90e-07 | 128 | 75 | 7 | int:EAF1 | |
| Interaction | STAC3 interactions | 5.37e-07 | 43 | 75 | 5 | int:STAC3 | |
| Interaction | CHD8 interactions | 5.97e-07 | 193 | 75 | 8 | int:CHD8 | |
| Interaction | NR2C2 interactions | FAM133B NOLC1 SETD1A PPIG VRK3 ZCCHC10 TCOF1 NKAPD1 ZMYND8 DVL3 KRI1 CHD1 CHD2 RP9 NKAP PAF1 AP3B1 CWC22 PTCD3 | 6.09e-07 | 1403 | 75 | 19 | int:NR2C2 |
| Interaction | SRRM1 interactions | NOLC1 GTF2E1 GTF2F1 BRD2 ZCCHC10 UBR5 NKAPD1 BRD4 WDR70 PAF1 | 6.35e-07 | 348 | 75 | 10 | int:SRRM1 |
| Interaction | POLR1E interactions | 6.69e-07 | 350 | 75 | 10 | int:POLR1E | |
| Interaction | DAXX interactions | 7.23e-07 | 353 | 75 | 10 | int:DAXX | |
| Interaction | GTF2B interactions | 9.43e-07 | 141 | 75 | 7 | int:GTF2B | |
| Interaction | GTF2F2 interactions | 1.04e-06 | 143 | 75 | 7 | int:GTF2F2 | |
| Interaction | CACTIN interactions | 1.09e-06 | 144 | 75 | 7 | int:CACTIN | |
| Interaction | SSRP1 interactions | RTF1 NOLC1 SETD2 BRD2 UBR5 DROSHA BRD4 ZMYND8 ANKRD11 CHD1 CHD2 PAF1 CBX2 | 1.31e-06 | 685 | 75 | 13 | int:SSRP1 |
| Interaction | DCAF4 interactions | SETD1A SETD2 FAM193A SETD1B TCOF1 UBR5 GPATCH1 KRI1 CHD1 DCAF5 | 1.34e-06 | 378 | 75 | 10 | int:DCAF4 |
| Interaction | RTF1 interactions | 1.43e-06 | 150 | 75 | 7 | int:RTF1 | |
| Interaction | KCNE3 interactions | 1.51e-06 | 296 | 75 | 9 | int:KCNE3 | |
| Interaction | JPH3 interactions | 1.88e-06 | 55 | 75 | 5 | int:JPH3 | |
| Interaction | MED6 interactions | 2.08e-06 | 101 | 75 | 6 | int:MED6 | |
| Interaction | RASA2 interactions | 2.49e-06 | 26 | 75 | 4 | int:RASA2 | |
| Interaction | FAM9A interactions | 2.67e-06 | 59 | 75 | 5 | int:FAM9A | |
| Interaction | MED19 interactions | 2.75e-06 | 106 | 75 | 6 | int:MED19 | |
| Interaction | TAF7 interactions | 3.07e-06 | 108 | 75 | 6 | int:TAF7 | |
| Interaction | NOLC1 interactions | 3.26e-06 | 325 | 75 | 9 | int:NOLC1 | |
| Interaction | TSSC4 interactions | 3.60e-06 | 111 | 75 | 6 | int:TSSC4 | |
| Interaction | CBX3 interactions | RTF1 SETD1A SETD2 GTF2E1 BRD2 TCOF1 BRD4 WDR70 ZMYND8 SNRK CHD1 RP9 | 4.38e-06 | 646 | 75 | 12 | int:CBX3 |
| Interaction | POLR2A interactions | SETD1A SETD2 PPIG GTF2E1 GTF2F1 SETD1B GPBP1 BRD4 CTDP1 AFF1 PAF1 | 4.47e-06 | 536 | 75 | 11 | int:POLR2A |
| Interaction | IWS1 interactions | 4.65e-06 | 116 | 75 | 6 | int:IWS1 | |
| Interaction | CEP70 interactions | 5.83e-06 | 262 | 75 | 8 | int:CEP70 | |
| Interaction | COIL interactions | RTF1 NOLC1 GTF2E1 GTF2F1 BRD2 ZCCHC10 NKAPD1 ANKRD11 CHD1 PAF1 AFF4 | 5.91e-06 | 552 | 75 | 11 | int:COIL |
| Interaction | MED8 interactions | 5.94e-06 | 121 | 75 | 6 | int:MED8 | |
| Interaction | KANSL2 interactions | 6.25e-06 | 70 | 75 | 5 | int:KANSL2 | |
| Interaction | RAD18 interactions | 7.23e-06 | 457 | 75 | 10 | int:RAD18 | |
| Interaction | RPL31 interactions | RTF1 NOLC1 GTF2F1 DCAF8 BRD2 TCOF1 NKAPD1 BRD4 ANKRD11 KRI1 RP9 PAF1 | 7.37e-06 | 680 | 75 | 12 | int:RPL31 |
| Interaction | CHST5 interactions | 7.54e-06 | 34 | 75 | 4 | int:CHST5 | |
| Interaction | PPIG interactions | 7.85e-06 | 127 | 75 | 6 | int:PPIG | |
| Interaction | H2BC8 interactions | RTF1 MBTD1 GTF2F1 BRD2 BRD4 WDR70 ZMYND8 GON4L CHD1 RP9 CBX2 | 8.83e-06 | 576 | 75 | 11 | int:H2BC8 |
| Interaction | DNAJC17 interactions | 1.07e-05 | 134 | 75 | 6 | int:DNAJC17 | |
| Interaction | PRPF3 interactions | 1.25e-05 | 291 | 75 | 8 | int:PRPF3 | |
| Interaction | SRPK2 interactions | RTF1 NOLC1 SETD2 PPIG GTF2E1 TCOF1 DROSHA WDR70 KRI1 CHD2 NKAP PTCD3 | 1.26e-05 | 717 | 75 | 12 | int:SRPK2 |
| Interaction | PXK interactions | 1.61e-05 | 41 | 75 | 4 | int:PXK | |
| Interaction | SMC5 interactions | NOLC1 SETD2 BRD2 BRD4 GPATCH1 ZMYND8 ANKRD11 KRI1 CHD1 RP9 PAF1 CWC22 AFF4 CBX2 | 1.65e-05 | 1000 | 75 | 14 | int:SMC5 |
| Interaction | H2AC4 interactions | 1.75e-05 | 506 | 75 | 10 | int:H2AC4 | |
| Interaction | PARP1 interactions | RTF1 NOLC1 SETD1A GTF2E1 GTF2F1 THRA BRD2 VRK3 NKAPD1 BRD4 WDR70 KRI1 CHD1 PAF1 AFF4 CBX2 | 2.17e-05 | 1316 | 75 | 16 | int:PARP1 |
| Interaction | FBL interactions | 2.32e-05 | 639 | 75 | 11 | int:FBL | |
| Interaction | CTR9 interactions | 2.57e-05 | 233 | 75 | 7 | int:CTR9 | |
| Interaction | VANGL1 interactions | 2.64e-05 | 234 | 75 | 7 | int:VANGL1 | |
| Interaction | ZCCHC10 interactions | 2.79e-05 | 236 | 75 | 7 | int:ZCCHC10 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 5.75e-08 | 4 | 45 | 3 | 1145 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.20e-06 | 9 | 45 | 3 | 1280 | |
| GeneFamily | WD repeat domain containing | 4.43e-05 | 262 | 45 | 6 | 362 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.17e-05 | 34 | 45 | 3 | 487 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Paf1/RNA polymerase II complex | 9.03e-05 | 6 | 45 | 2 | 1029 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 9.04e-04 | 18 | 45 | 2 | 498 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 1.12e-03 | 20 | 45 | 2 | 1371 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 1.75e-03 | 25 | 45 | 2 | 565 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 7.50e-08 | 363 | 74 | 10 | M41103 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SETD2 KANK1 GPBP1L1 DCAF8 KLF6 TEX2 NKAPD1 GON4L SNRK CHD2 AFF4 | 1.57e-05 | 807 | 74 | 11 | M16651 |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 JCAD GTF2E1 UTP25 ZCCHC10 TCOF1 NAF1 CHD1 SHQ1 CBX2 PTCD3 | 4.44e-05 | 904 | 74 | 11 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 JCAD GTF2E1 UTP25 ZCCHC10 TCOF1 NAF1 CHD1 SHQ1 CBX2 PTCD3 | 5.30e-05 | 922 | 74 | 11 | MM1068 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SETD2 PPIG CLSTN3 PTPRC GPBP1 KLF6 UBR5 ANKRD11 KRI1 SNRK CHD1 CHD2 STK24 DCAF5 | 6.44e-05 | 1492 | 74 | 14 | M40023 |
| Coexpression | GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | 1.39e-04 | 175 | 74 | 5 | M6909 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | PPIG GPBP1L1 EAF2 UTP25 UBR5 NKAPD1 STK26 WDR70 ZMYND8 AFF1 RFWD3 SHQ1 | 1.43e-04 | 1215 | 74 | 12 | M41122 |
| Coexpression | TBK1.DF_DN | 1.59e-04 | 286 | 74 | 6 | M2864 | |
| Coexpression | MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN | 2.29e-04 | 42 | 74 | 3 | M1552 | |
| Coexpression | GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP | 2.41e-04 | 197 | 74 | 5 | M8166 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP | 2.47e-04 | 198 | 74 | 5 | M3129 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.53e-04 | 199 | 74 | 5 | M7254 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP | 2.53e-04 | 199 | 74 | 5 | M3846 | |
| Coexpression | GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 2.53e-04 | 199 | 74 | 5 | M6926 | |
| Coexpression | GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN | 2.53e-04 | 199 | 74 | 5 | M6928 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 2.59e-04 | 200 | 74 | 5 | M5055 | |
| Coexpression | GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP | 2.59e-04 | 200 | 74 | 5 | M7783 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN | 2.59e-04 | 200 | 74 | 5 | M5806 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN | 2.59e-04 | 200 | 74 | 5 | M5005 | |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP | 2.59e-04 | 200 | 74 | 5 | M6357 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 2.59e-04 | 200 | 74 | 5 | M7839 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 2.59e-04 | 200 | 74 | 5 | M4979 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | RTF1 MBTD1 PPIG GTF2E1 ZCCHC10 NKAPD1 GPATCH1 CHD2 AP3B1 STK24 SHQ1 | 3.87e-06 | 564 | 74 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SETD2 PPIG FAM193A UBR5 NPAS3 GON4L CHD1 CHD2 RP9 NKAP AP3B1 AFF4 | 2.81e-05 | 831 | 74 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 SETD2 PPIG FAM193A TCOF1 UBR5 NPAS3 CHD1 CHD2 RP9 AP3B1 CWC22 RFWD3 | 3.34e-05 | 989 | 74 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-09 | 188 | 75 | 8 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.74e-08 | 200 | 75 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 184 | 75 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-07 | 187 | 75 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.05e-06 | 198 | 75 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 9.02e-06 | 166 | 75 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.23e-05 | 177 | 75 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 182 | 75 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 183 | 75 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.44e-05 | 183 | 75 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 183 | 75 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 185 | 75 | 5 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.60e-05 | 187 | 75 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.64e-05 | 188 | 75 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.82e-05 | 192 | 75 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 194 | 75 | 5 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 194 | 75 | 5 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 194 | 75 | 5 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 2.06e-05 | 197 | 75 | 5 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.16e-05 | 199 | 75 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.16e-05 | 199 | 75 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.21e-05 | 200 | 75 | 5 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.21e-05 | 200 | 75 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.21e-05 | 200 | 75 | 5 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.21e-05 | 200 | 75 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 8.70e-05 | 138 | 75 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| Drug | 6-azauracil | 1.26e-07 | 72 | 74 | 6 | CID000068037 | |
| Drug | 3-deazacytidine | 4.83e-06 | 206 | 74 | 7 | CID000001652 | |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 5.87e-06 | 2 | 72 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | JCAD SETD2 GPBP1L1 ZCCHC10 EVA1A GPATCH1 GON4L AFF1 FBXL19 DCAF5 | 7.30e-05 | 914 | 72 | 10 | EFO_0004532 |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 8.75e-05 | 6 | 72 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | multiple myeloma | 1.66e-04 | 112 | 72 | 4 | EFO_0001378 | |
| Disease | mean platelet volume | JCAD SETD2 SETD1B PTPRC TEX2 ZMYND8 ANKRD11 AFF1 CWC22 DCAF5 | 1.79e-04 | 1020 | 72 | 10 | EFO_0004584 |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 2.09e-04 | 9 | 72 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 3.18e-04 | 11 | 72 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 7.80e-04 | 17 | 72 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 7.80e-04 | 17 | 72 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 7.80e-04 | 17 | 72 | 2 | C0154060 | |
| Disease | Intellectual Disability | 7.85e-04 | 447 | 72 | 6 | C3714756 | |
| Disease | basophil count | 1.17e-03 | 483 | 72 | 6 | EFO_0005090 | |
| Disease | advanced glycosylation end product-specific receptor ligand measurement | 1.20e-03 | 21 | 72 | 2 | EFO_0010762 | |
| Disease | Stomach Carcinoma | 1.20e-03 | 21 | 72 | 2 | C0699791 | |
| Disease | chronic obstructive pulmonary disease | 1.44e-03 | 688 | 72 | 7 | EFO_0000341 | |
| Disease | Neurodevelopmental Disorders | 1.54e-03 | 93 | 72 | 3 | C1535926 | |
| Disease | gastroesophageal reflux disease | 1.96e-03 | 101 | 72 | 3 | EFO_0003948 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.19e-03 | 105 | 72 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | Epilepsy | 2.43e-03 | 109 | 72 | 3 | C0014544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFDLSSDSESSSESE | 451 | Q9Y5B0 | |
| SSEESSTESSEEEDA | 291 | Q6UB99 | |
| SESESSESGEDDRDS | 481 | Q6UB99 | |
| DSSDSEVADSPSSDE | 931 | Q9BQT9 | |
| DSSSDSDSSTDDSEE | 491 | O60885 | |
| SESESSSESSSSDSE | 701 | O60885 | |
| SSESSSSDSEDSETE | 706 | O60885 | |
| SSSESESSSESDSDT | 486 | P51816 | |
| ESSSESDSDTESSTT | 491 | P51816 | |
| SDSDTESSTTDSESN | 496 | P51816 | |
| SDSSDSTSDSNDESD | 1256 | Q9NZW4 | |
| DSDEDDSTSRFSSST | 191 | Q92997 | |
| GSEEDSSSSEDSDDS | 121 | O14646 | |
| SSSSEDSDDSSSEVK | 126 | O14646 | |
| ISSTSSSSSEADDEE | 346 | P78312 | |
| DSESESSSSDSEANE | 441 | Q9UHB7 | |
| YSESEEEEDSSDSSS | 676 | O00203 | |
| EEEDSSDSSSDSESE | 681 | O00203 | |
| DSSNDESSSIEDSSS | 766 | O00203 | |
| ESSSIEDSSSDSESE | 771 | O00203 | |
| EDSSSDSESESEPES | 776 | O00203 | |
| PDTSSSSSDSDSDSD | 321 | Q6PCT2 | |
| DSDSDSSGTSLSEDE | 331 | Q6PCT2 | |
| AKASESSSSEESSDD | 121 | Q14978 | |
| SSSSSSSDDSEEEKA | 221 | Q14978 | |
| TRKSSSSEDSSSDEE | 261 | Q14978 | |
| SSEDSSDESDSSSEE | 321 | Q14978 | |
| SSSDSSDSDSSEDDE | 361 | Q14978 | |
| ADSSSSEEESSSSEE | 421 | Q14978 | |
| SRDSSSDSDSSSSEE | 466 | Q14978 | |
| SDSDSSSSEEEEEKT | 471 | Q14978 | |
| SSNSSSSDDSSEEEE | 516 | Q14978 | |
| EELQVSSSSDSDSDS | 206 | Q6PCD5 | |
| ESSSDSSDSEDGSED | 76 | Q9H8M9 | |
| SDSDTDSSSDSDSDT | 671 | Q96EY7 | |
| SDSSSSSSDSEDEEK | 111 | Q8N9E0 | |
| DSCSEDTSSSSSSEE | 6 | Q05BQ5 | |
| DTSSSSSSEESEEEV | 11 | Q05BQ5 | |
| EDSDTETSSSETSDD | 456 | Q9HC44 | |
| ENDDTETSSSDTSDD | 456 | Q86WP2 | |
| ELQEEEESSSSSSSS | 841 | Q9P266 | |
| DSSDSDSDSSDSSSE | 681 | Q9HCG8 | |
| DSDSSDSSSESSSEE | 686 | Q9HCG8 | |
| EESDESSSTSETSEE | 606 | P0C7V8 | |
| SSESSDSSDSQSDEE | 896 | Q9BRR8 | |
| ADSDESPSSSDTSDE | 571 | Q5TAQ9 | |
| SSSSSSSSEDEEELN | 561 | Q96JK2 | |
| SSSDESSSSESDDEC | 1011 | Q14678 | |
| SSSDSSSESDSSDER | 41 | Q8N9T8 | |
| DSSDSDATASSDNSE | 66 | Q8NBZ0 | |
| QSSSDSSDSESATEE | 211 | Q13427 | |
| SEAAASDSSEADSDS | 516 | Q8N7H5 | |
| SSSSSDEEDDSDLDA | 116 | Q14781 | |
| SSSSSEDSSSDSEDE | 186 | Q96CJ1 | |
| SSDSSSSSSDSEDED | 111 | Q5BKY9 | |
| SISGSEDSDSASEED | 126 | Q9H8Y5 | |
| SSESSESQSESESES | 56 | O14647 | |
| SSEDEDDATSTSNAD | 2211 | Q3T8J9 | |
| ELDESSSTSDTSEEE | 576 | A6NGE4 | |
| DDSSDDSEASDDSSD | 276 | Q96QF7 | |
| DSEASDDSSDDSEAS | 281 | Q96QF7 | |
| DDSSDDSEASDDSSD | 286 | Q96QF7 | |
| HSDSEDSEKSDSSDS | 586 | Q9ULU4 | |
| DSESESDVGSSSDTD | 231 | Q05469 | |
| EDSDSDSDSETDSSD | 211 | Q8N5F7 | |
| SSDSDSSSEDEEFHD | 166 | Q92541 | |
| GSDSESETSESDDDS | 351 | P29083 | |
| SSEESDSSEESDIDS | 341 | P35269 | |
| DSSEESDIDSEASSA | 346 | P35269 | |
| ESSDSSDSESDSESE | 51 | Q68CQ4 | |
| ESDEDSTCSSSSDSE | 486 | Q9NRR4 | |
| DSTSDEDRSSSSSSE | 166 | Q8TA86 | |
| ADSSSEDTSSSSDET | 196 | Q13428 | |
| EEDSESSSEESSDSE | 336 | Q13428 | |
| SSSEESSDSEEETPA | 341 | Q13428 | |
| DNSESSEESSDSADS | 606 | Q13428 | |
| ESTARSSSSESEDED | 991 | Q13428 | |
| ESSDDSEDSSDSSSG | 1141 | Q13428 | |
| SHDDSSSEDSDAETD | 311 | Q9Y6E0 | |
| DDESDSEGSDSESTS | 301 | Q9P289 | |
| SSEVSSEEEDSSTES | 436 | Q1XH10 | |
| SEEEDSSTESDSSSG | 441 | Q1XH10 | |
| SSEASDSEDSDSSVS | 451 | Q6PI26 | |
| SSTSSTSDKDDDDDD | 1096 | Q9UPS6 | |
| EATSSSESSESSEFE | 1151 | Q9UPS6 | |
| SESSESSEFESSSES | 1156 | Q9UPS6 | |
| SSSESSPSSSEDEEE | 1166 | Q9UPS6 | |
| SESSETSDSESDSKD | 456 | Q8IXF0 | |
| SDGDSSSVDSDDSIE | 521 | Q5T8A7 | |
| SSCSSSETSDDDSES | 536 | Q9NRH2 | |
| EEEEESSDSSSSSDG | 1371 | O15047 | |
| SSEESSSESSSEEEE | 481 | P25440 | |
| SEFSDSSLSADDADT | 2196 | Q13023 | |
| SDSESESSSSDSEEN | 481 | P51825 | |
| SSFSEDDDSASTSEE | 36 | P29973 | |
| DDSASSSSEESEERD | 231 | Q6ZUT1 | |
| STTDEDSSCSSDDEA | 2671 | O15417 | |
| TSSSESEQSSDSSDD | 101 | Q9NW82 | |
| DSSESEDTLSSSERS | 81 | Q8IV63 | |
| SDSSASDSSSESEET | 116 | Q8TBK6 | |
| ESEETSTSSSSEDSD | 126 | Q8TBK6 | |
| STSSSSEDSDTDESS | 131 | Q8TBK6 | |
| SSESSNDESDSEDTD | 1041 | Q9BYW2 | |
| EDDSSEADSPSSSEE | 461 | P10827 | |
| ISEEEDDTSSEATSS | 156 | Q96NL1 | |
| SDEESSSAGSSEEDD | 946 | Q8IWB9 | |
| SDESSDDDSDSEEPS | 1001 | P08575 | |
| SSDSDSSSSQSDDIE | 1671 | O95071 | |
| SDVSSESSDSSEELS | 106 | Q99612 | |
| LETSDSDSDSDSETD | 111 | Q96HR8 | |
| SDSDSDSETDSDSSS | 116 | Q96HR8 |